Search

Your search keyword '"Kramer, Michal"' showing total 269 results
Start Over Author "Kramer, Michal"
269 results on '"Kramer, Michal"'

3. Recurrent and chronic anterior uveitis: Long-term outcome and treatment strategies

Author

Sharon, Yael, Goren, Lee, Barayev, Edward, Neumann, Ron, Chu, David, and Kramer, Michal

Subjects
Medical research, Medicine, Experimental, Uveitis -- Care and treatment -- Patient outcomes, Health
Abstract

Byline: Yael. Sharon, Lee. Goren, Edward. Barayev, Ron. Neumann, David. Chu, Michal. Kramer Purpose: To study the long-term clinical outcome and treatment strategies of recurrent and chronic non-infectious anterior uveitis. [...]

Published
2024

8. Retinal vascular occlusions in ocular Behçet disease – a comparative analysis.

Author

Ostrovsky, Michael, Ramon, Dan, Iriqat, Salam, Shteiwi, Abdallah, Sharon, Yael, Kramer, Michal, Vishnevskia‐Dai, Vicktoria, Sar, Shaul, Boulos, Yosif, Tomkins‐Netzer, Oren, Lavee, Natalie, Ben‐Arie‐Weintrob, Yael, Pizem, Hadas, Hareuveni‐Blum, Tamar, Schneck, Marina, Gepstein, Raz, Masarwa, Dua, Nakhoul, Nakhoul, Bakshi, Erez, and Shulman, Shiri

Subjects
RETINAL vein occlusion, JEWISH identity, ARTERIAL occlusions, RETINAL artery occlusion, FLUORESCENCE angiography
Abstract

Purpose: The literature on retinal vascular occlusions in Behçet disease (BD) patients is limited. The aim of this study is to thoroughly investigate retinal vascular occlusions among ocular BD patients. Methods: Retrospective, multicentre case–control study. Three‐hundred and three eyes of 175 patients with ocular BD, from 13 hospitals in Israel and Palestine, were included. Patients were assigned into two groups according to the presence of retinal vascular occlusion. Epidemiology, systemic and ocular manifestations, treatments and outcomes were compared between the groups and risk factors for retinal vascular occlusions were identified. Results: One hundred twenty‐five patients (71.4%) were male. The mean age at presentation was 28.2 ± 0.86 years. Retinal vascular occlusions were found in 80 eyes of 54 (30.9%) patients, including branch retinal vein occlusion (51.3%), peripheral vessels occlusions (32.5%), central retinal vein occlusion (13.8%) and arterial occlusions (7.5%). Systemic manifestations were similar among both groups. Anterior uveitis was more common in non‐occlusive eyes (p < 0.01). Non‐occlusive retinal vasculitis (p = 0.03) and ocular complications were more common in occlusive eyes (p < 0.01). Treatments including mycophenolate mofetil, Infliximab or a combination therapy of anti‐metabolite and calcineurin inhibitor were more commonly used by occlusive patients (p < 0.05). Occlusive patients underwent more cataract surgeries (p = 0.03). The occlusive group had worse mean best‐corrected visual acuity (BCVA) throughout follow‐up (p < 0.01). Risk factors for retinal vascular occlusions included male sex and Jewish ethnicity (p < 0.05). Conclusion: Retinal vascular occlusions were found in a third of ocular BD patients. Occlusive eyes had a worse prognosis. Risk factors for vascular occlusions were identified. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

10. Ocular Behçet Disease—Clinical Manifestations, Treatments and Outcomes According to Age at Disease Onset

Author

Ostrovsky, Michael, primary, Rosenblatt, Amir, additional, Iriqat, Salam, additional, Shteiwi, Abdallah, additional, Sharon, Yael, additional, Kramer, Michal, additional, Vishnevskia-Dai, Vicktoria, additional, Sar, Shaul, additional, Boulos, Yosif, additional, Tomkins-Netzer, Oren, additional, Lavee, Natalie, additional, Ben-Arie-Weintrob, Yael, additional, Pizem, Hadas, additional, Hareuveni-Blum, Tamar, additional, Schneck, Marina, additional, Gepstein, Raz, additional, Masarwa, Dua, additional, Nakhoul, Nakhoul, additional, Bakshi, Erez, additional, Shulman, Shiri, additional, Goldstein, Michaella, additional, Ramon, Dan, additional, Anouk, Marina, additional, and Habot-Wilner, Zohar, additional

Published
2023
Full Text
View/download PDF

25. Tarsier Anterior Chamber Cell Grading: Improving the SUN Grading Scheme with a Visual Analog Scale.

Author

de Smet, Marc D., Haim-Langford, Daphne, Neumann, Ron, Kramer, Michal, Cunningham, Emmett, Deutsch, Lisa, and Milman, Zohar

Subjects
VISUAL analog scale, UVEITIS, ANTERIOR chamber (Eye)
Abstract

To compare an analog visual scale in grading anterior chamber cells (ACC) to a modified Standardization of Uveitis Nomenclature (SUN) ACC scale. A graphical representation of anterior chamber cells as a reference and a test set was created and shown to two groups of experienced uveitis experts. Group 1 was given the analog scale in written format, while group two was given the reference images for comparison. Each test subject was asked to provide the best approximation for each grade. Eleven graders participated in phase 1. Correct grading occurred in 87.4% of cases. Discrepancies were seen at all grades. Only 3 of 11 graders were able to achieve a perfect score. Seven graders participated in phase 2. Agreement was 95.2% with 4/7 graders achieving a perfect score. Discrepancies were seen at higher grades only. ACC grading is improved by a visual grading scale, and interobserver variability is reduced. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

29. Long-Term Safety and Efficacy of Adalimumab in Patients with Noninfectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis

Author

Suhler, Eric B., primary, Jaffe, Glenn J., additional, Fortin, Eric, additional, Lim, Lyndell L., additional, Merrill, Pauline T., additional, Dick, Andrew D., additional, Brezin, Antoine P., additional, Nguyen, Quan Dong, additional, Thorne, Jennifer E., additional, Van Calster, Joachim, additional, Cimino, Luca, additional, Adan, Alfredo, additional, Goto, Hiroshi, additional, Kaburaki, Toshikatsu, additional, Kramer, Michal, additional, Vitale, Albert T., additional, Kron, Martina, additional, Song, Alexandra P., additional, Liu, Jianzhong, additional, Pathai, Sophia, additional, Douglas, Kevin M., additional, Schlaen, Ariel, additional, Muccioli, Cristina, additional, Van Velthoven, Mirjam E.J., additional, Zierhut, Manfred, additional, and Rosenbaum, James T., additional

Published
2021
Full Text
View/download PDF

30. Noninfectious Intermediate, Posterior, or Panuveitis: Results from the Retrospective, Observational, International EyeCOPE Study

Author

Kramer Michal, Brichova Michaela, Tugal-Tutkun Ilknur, Panchenko Mykola, Gormezano Natali, Koenigsbauer Franziska, Franco Pablo, Muccioli Cristina, Hasanreisoglu Murat and International EyeCOPE Study Group.

Subjects
genetic structures, Corticosteroid disease burden, Disease characteristics, Immunosuppressants, Noninfectious uveitis, Patient-reported outcomes, eye diseases
Abstract

Introduction: The EyeCOPE study characterized noninfectious intermediate posterior, or panuveitis (NIIPPU) before biologic agents were widely available. Methods: This retrospective, observational study included adults with NIIPPU attending a routine ophthalmological visit. Data were collected from the study visit and medical records. Results: Of 565 patients, 58.8% were female, and the mean age was 41.3 years ; 33.8% had idiopathic uveitis and 45.8% had panuveitis. The median time from symptom onset to diagnosis and treatment was 27.0 and 30.5 days, respectively. Patients received immunosuppressants and systemic/local corticosteroids. Most patients experienced substantial decline in ocular function (mean best corrected visual acuity, 0.4 logMAR). Mean total work productivity impairment among employed patients was 31.0%. Most patients reported ocular complications (70.8%) such as vision loss and cataracts. Conclusions: Despite treatment, most patients with NIIPPU experienced a decline in ocular function and ocular complications. There is an unmet need for additional NIIPPU treatment, such as targeted monoclonal antibodies.

Published
2021

31. Drug-induced Sarcoid Uveitis with Biologics.

Author

Sobolewska, Bianka, Baglivo, Edoardo, Edwards, Albert O., Kramer, Michal, Miserocchi, Elisabetta, Palestine, Alan G., Schwab, Ivan R., Zamir, Ehud, Doycheva, Deshka, and Zierhut, Manfred

Abstract

to evaluate new onset uveitis or reactivated uveitis by biologic agents and characterize their features. This is a multicenter, retrospective case series. Patients under biologic therapy were included if they developed uveitis for the first time or experienced intraocular inflammation which was different in location or laterality to previous inflammation. Sixteen patients were identified. The underlying disorders included ankylosing spondylitis, juvenile idiopathic arthritis, rheumatoid arthritis, and Behçet's Disease. The biologic agents associated with a first episode of uveitis (n = 11) or with a new recurrence of uveitis (n = 5) were etanercept, adalimumab, abatacept, infliximab, and golimumab. Sarcoidosis based on bihilar lymphadenopathy, other computer tomography-findings, or biopsy was diagnosed in five patients under therapy with etanercep, adalimumab, and abatacept. Additionally, seven patients developed clinical changes in their uveitis pattern, suggesting sarcoid uveitis. Biologic treatment-induced uveitis often presents as granulomatous disease. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

34. Drug-induced Sarcoid Uveitis with Biologics

Author

Sobolewska, Bianka, primary, Baglivo, Edoardo, additional, Edwards, Albert O., additional, Kramer, Michal, additional, Miserocchi, Elisabetta, additional, Palestine, Alan G., additional, Schwab, Ivan R., additional, Zamir, Ehud, additional, Doycheva, Deshka, additional, and Zierhut, Manfred, additional

Published
2021
Full Text
View/download PDF

35. Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis—Report 1

Author

Agrawal, Rupesh, primary, Testi, Ilaria, additional, Mahajan, Sarakshi, additional, Yuen, Yew Sen, additional, Agarwal, Aniruddha, additional, Kon, Onn Min, additional, Barisani-Asenbauer, Talin, additional, Kempen, John H., additional, Gupta, Amod, additional, Jabs, Douglas A., additional, Smith, Justine R., additional, Nguyen, Quan Dong, additional, Pavesio, Carlos, additional, Gupta, Vishali, additional, Agarwal, Mamta, additional, Agarwal, Manisha, additional, Aggarwal, Ashutosh, additional, Aggarwal, Kanika, additional, Agrawal, Mukesh, additional, Al-Dhibi, Hassan, additional, Androudi, Sofia, additional, Asyari, Fatma, additional, Balasundaram, Manohar Babu, additional, Murthy, Kalpana Babu, additional, Baglivo, Edoardo, additional, Banker, Alay, additional, Bansal, Reema, additional, Basu, Soumyava, additional, Behera, Digamber, additional, Biswas, Jyotirmay, additional, Bodaghi, Bahram, additional, Carreño, Ester, additional, Caspers, Laure, additional, Chee, Soon Phaik, additional, Chhabra, Romi, additional, Cimino, Luca, additional, Concha del Rio, Luz Elena, additional, Cunningham, Emmett T., additional, Land Curi, Andrè Luiz, additional, Das, Dipankar, additional, Davis, Janet, additional, DeSmet, Marc, additional, Denisova, Ekaterina, additional, Denniston, Alastair K., additional, Errera, Marie-Hélène, additional, Fonollosa, Alejandro, additional, George, Amala, additional, Goldstein, Debra A., additional, Crosier, Yan Guex, additional, Gunasekeran, Dinesh Visva, additional, Gurbaxani, Avinash, additional, Invernizzi, Alessandro, additional, Isa, Hazlita M., additional, Islam, Shah Md., additional, Jones, Nicholas, additional, Katoch, Deeksha, additional, Khairallah, Moncef, additional, Khosla, Amit, additional, Kramer, Michal, additional, Kumar, Amitabh, additional, Kumar, Atul, additional, La Distia Nora, Rina, additional, Lee, Richard, additional, Lowder, Careen, additional, Luthra, Saurabh, additional, Mahendradas, Padmamalini, additional, Makhoul, Dorine, additional, Mazumdar, Shahana, additional, McCluskey, Peter, additional, Mehta, Salil, additional, Miserocchi, Elisabetta, additional, Mochizuki, Manabu, additional, Mohamed, Oli S., additional, Muccioli, Cristina, additional, Munk, Marion R., additional, Murthy, Somasheila, additional, Narain, Shishir, additional, Nascimento, Heloisa, additional, Neri, Piergiorgio, additional, Nguyen, Myhanh, additional, Okada, Annabelle A., additional, Ozdal, Pinar, additional, Palestine, Alan, additional, Pichi, Francesco, additional, Raje, Dhananjay, additional, Rathinam, S.R., additional, Rousselot, Andres, additional, Schlaen, Ariel, additional, Sehgal, Shobha, additional, Sen, H. Nida, additional, Sharma, Aman, additional, Sharma, Kusum, additional, Shoughy, Samir S., additional, Singh, Nirbhai, additional, Singh, Ramandeep, additional, Soheilian, Masoud, additional, Sridharan, Sudharshan, additional, Thorne, Jennifer E., additional, Tappeiner, Christoph, additional, Teoh, Stephen, additional, Tognon, Maria Sofia, additional, Tugal-Tutkun, Ilknur, additional, Tyagi, Mudit, additional, Uy, Harvey, additional, Vasconcelos Santos, Daniel Vitor, additional, Valentincic, Natasa Vidovic, additional, Westcott, Mark, additional, Yanai, Ryoji, additional, Alvarez, Bety Yanez, additional, Zahedur, Rahman, additional, and Zierhut, Manfred, additional

Published
2021
Full Text
View/download PDF

36. Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis—Report 2

Author

Agrawal, Rupesh, primary, Testi, Ilaria, additional, Bodaghi, Baharam, additional, Barisani-Asenbauer, Talin, additional, McCluskey, Peter, additional, Agarwal, Aniruddha, additional, Kempen, John H., additional, Gupta, Amod, additional, Smith, Justine R., additional, de Smet, Marc D., additional, Yuen, Yew Sen, additional, Mahajan, Sarakshi, additional, Kon, Onn Min, additional, Nguyen, Quan Dong, additional, Pavesio, Carlos, additional, Gupta, Vishali, additional, Agrawal, Rupesh, additional, Agarwal, Mamta, additional, Agarwal, Manisha, additional, Aggarwal, Ashutosh, additional, Aggarwal, Kanika, additional, Agrawal, Mukesh, additional, Al-Dhibi, Hassan, additional, Androudi, Sofia, additional, Asyari, Fatma, additional, Balasundaram, Manohar Babu, additional, Murthy, Kalpana Babu, additional, Baglivo, Edoardo, additional, Banker, Alay, additional, Bansal, Reema, additional, Basu, Soumyava, additional, Behera, Digamber, additional, Biswas, Jyotirmay, additional, Carreño, Ester, additional, Caspers, Laure, additional, Chee, Soon Phaik, additional, Chhabra, Romi, additional, Cimino, Luca, additional, Concha del Rio, Luz Elena, additional, Cunningham, Emmett T., additional, Land Curi, Andrè Luiz, additional, Das, Dipankar, additional, Davis, Janet, additional, DeSmet, Marc, additional, Denisova, Ekaterina, additional, Denniston, Alastair K., additional, Errera, Marie-Hélène, additional, Fonollosa, Alejandro, additional, George, Amala, additional, Goldstein, Debra A., additional, Crosier, Yan Guex, additional, Gunasekeran, Dinesh Visva, additional, Gurbaxani, Avinash, additional, Invernizzi, Alessandro, additional, Isa, Hazlita M., additional, Islam, Shah M.d., additional, Jones, Nicholas, additional, Katoch, Deeksha, additional, Khairallah, Moncef, additional, Khosla, Amit, additional, Kramer, Michal, additional, Kumar, Amitabh, additional, Kumar, Atul, additional, La Distia Nora, Rina, additional, Lee, Richard, additional, Lowder, Careen, additional, Luthra, Saurabh, additional, Mahendradas, Padmamalini, additional, Makhoul, Dorine, additional, Mazumdar, Shahana, additional, Mehta, Salil, additional, Miserocchi, Elisabetta, additional, Mochizuki, Manabu, additional, Mohamed, Oli S., additional, Muccioli, Cristina, additional, Munk, Marion R., additional, Murthy, Somasheila, additional, Narain, Shishir, additional, Nascimento, Heloisa, additional, Neri, Piergiorgio, additional, Nguyen, Myhanh, additional, Okada, Annabelle A., additional, Ozdal, Pinar, additional, Palestine, Alan, additional, Pichi, Francesco, additional, Raje, Dhananjay, additional, Rathinam, S.R., additional, Rousselot, Andres, additional, Schlaen, Ariel, additional, Sehgal, Shobha, additional, Nida Sen, H., additional, Sharma, Aman, additional, Sharma, Kusum, additional, Shoughy, Samir S., additional, Singh, Nirbhai, additional, Singh, Ramandeep, additional, Soheilian, Masoud, additional, Sridharan, Sudharshan, additional, Thorne, Jennifer E., additional, Tappeiner, Christoph, additional, Teoh, Stephen, additional, Tognon, Maria Sofia, additional, Tugal-Tutkun, Ilknur, additional, Tyagi, Mudit, additional, Uy, Harvey, additional, Vasconcelos Santos, Daniel Vitor, additional, Valentincic, Natasa Vidovic, additional, Westcott, Mark, additional, Yanai, Ryoji, additional, Alvarez, Bety Yanez, additional, Zahedur, Rahman, additional, Zierhut, Manfred, additional, and Xian, Zheng, additional

Published
2021
Full Text
View/download PDF

41. The Collaborative Ocular Tuberculosis Study (COTS) Consensus (CON) Group Meeting Proceedings

Author

Agrawal, Rupesh, primary, Testi, Ilaria, additional, Mahajan, Sarakshi, additional, Yuen, Yew Sen, additional, Agarwal, Aniruddha, additional, Rousselot, Andres, additional, Raje, Dhananjay, additional, Gunasekeran, Dinesh Visva, additional, Kon, Onn Min, additional, Barisani-Asenbauer, Talin, additional, Kempen, John H., additional, Gupta, Amod, additional, Jabs, Douglas A., additional, Smith, Justine R., additional, Bodaghi, Bahram, additional, Zierhut, Manfred, additional, DeSmet, Marc, additional, Cluskey, Peter Mc, additional, Agarwal, Mamta, additional, Agarwal, Manisha, additional, Aggarwal, Kanika, additional, Agrawal, Mukesh, additional, Al-Dhibi, Hassan, additional, Androudi, Sofia, additional, Asyari, Fatma, additional, Balasundaram, Manohar Babu, additional, Murthy, Kalpana Babu, additional, Baglivo, Edoardo, additional, Banker, Alay, additional, Bansal, Reema, additional, Basu, Soumyava, additional, Behera, Digamber, additional, Biswas, Jyotirmay, additional, Carreño, Ester, additional, Caspers, Laure, additional, Chee, Soon Phaik, additional, Chhabra, Romi, additional, Cimino, Luca, additional, del Rio, Luz Elena Concha, additional, Cunningham, Emmett T., additional, Curi, Andrè Luiz Land, additional, Das, Dipankar, additional, Denisova, Ekaterina, additional, Denniston, Alastair K, additional, Errera, Marie-Hélène, additional, Fonollosa, Alejandro, additional, George, Amala, additional, Goldstein, Debra A., additional, Crosier, Yan Guex, additional, Gurbaxani, Avinash, additional, Invernizzi, Alessandro, additional, Isa, Hazlita M., additional, Md. Islam, Shah, additional, Jones, Nicholas, additional, Katoch, Deeksha, additional, Khairallah, Moncef, additional, Khosla, Amit, additional, Kramer, Michal, additional, Kumar, Amitabh, additional, Kumar, Atul, additional, Nora, Rina La Distia, additional, Lee, Richard, additional, Lowder, Careen, additional, Luthra, Saurabh, additional, Mahendradas, Padmamalini, additional, Makhoul, Dorine, additional, Mazumdar, Shahana, additional, Mehta, Salil, additional, Miserocchi, Elisabetta, additional, Mochizuki, Manabu, additional, Mohamed, Oli S., additional, Muccioli, Cristina, additional, Munk, Marion R, additional, Murthy, Somasheila, additional, Narain, Shishir, additional, Nascimento, Heloisa, additional, Neri, Piergiorgio, additional, Nguyen, Myhanh, additional, Okada, Annabelle A., additional, Ozdal, Pinar, additional, Palestine, Alan, additional, Pichi, Francesco, additional, Rathinam, S.R, additional, Schlaen, Ariel, additional, Sehgal, Shobha, additional, Sen, H Nida, additional, Sharma, Aman, additional, Sharma, Kusum, additional, Shoughy, Samir S., additional, Singh, Nirbhai, additional, Singh, Ramandeep, additional, Soheilian, Masoud, additional, Sridharan, Sudharshan, additional, Thorne, Jennifer E., additional, Tappeiner, Christoph, additional, Teoh, Stephen, additional, Tognon, Maria Sofia, additional, Tugal-Tutkun, Ilknur, additional, Tyagi, Mudit, additional, Uy, Harvey, additional, Santos, Daniel Vitor Vasconcelos, additional, Valentincic, Natasa Vidovic, additional, Westcott, Mark, additional, Yanai, Ryoji, additional, Alvarez, Bety Yanez, additional, Zahedur, Rahman, additional, Nguyen, Quan Dong, additional, Pavesio, Carlos, additional, and Gupta, Vishali, additional

Published
2020
Full Text
View/download PDF

46. Noninfectious Intermediate, Posterior, or Panuveitis: Results from the Retrospective, Observational, International EyeCOPE Study.

Author

Kramer, Michal, Brichova, Michaela, Tugal-Tutkun, Ilknur, Panchenko, Mykola, Gormezano, Natali, Koenigsbauer, Franziska, Franco, Pablo, Muccioli, Cristina, Hasanreisoglu, Murat, International EyeCOPE Study Group, Altan, Ayse Cigdem, Amer, Radgonde, Becker, Matthias, Balta, Florian, Branisteanu, Daniel, Budmann, Gustavo, Silva, Thiago George Cabral, Ozdal, Muge Pinar Cakar, Cekic, Sonja, and Cherecheanu, Alina Popa

Subjects
*VISION disorders, *LABOR productivity, *BIOLOGICALS, *IRIDOCYCLITIS, *DIAGNOSIS, *PATIENTS' attitudes
Abstract

Introduction: The EyeCOPE study characterized noninfectious intermediate posterior, or panuveitis (NIIPPU) before biologic agents were widely available. Methods: This retrospective, observational study included adults with NIIPPU attending a routine ophthalmological visit. Data were collected from the study visit and medical records. Results: Of 565 patients, 58.8% were female, and the mean age was 41.3 years; 33.8% had idiopathic uveitis and 45.8% had panuveitis. The median time from symptom onset to diagnosis and treatment was 27.0 and 30.5 days, respectively. Patients received immunosuppressants and systemic/local corticosteroids. Most patients experienced substantial decline in ocular function (mean best corrected visual acuity, 0.4 logMAR). Mean total work productivity impairment among employed patients was 31.0%. Most patients reported ocular complications (70.8%) such as vision loss and cataracts. Conclusions: Despite treatment, most patients with NIIPPU experienced a decline in ocular function and ocular complications. There is an unmet need for additional NIIPPU treatment, such as targeted monoclonal antibodies. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

48. Imaging in tuberculosis-associated uveitis

Author

Bansal, Reema, Basu, Soumyava, Gupta, Amod, Rao, Narsing, Invernizzi, Alessandro, and Kramer, Michal

Subjects
Tuberculosis -- Diagnosis -- Care and treatment -- Complications and side effects -- Research, Uveitis -- Diagnosis -- Care and treatment -- Research, Health
Abstract

Byline: Reema. Bansal, Soumyava. Basu, Amod. Gupta, Narsing. Rao, Alessandro. Invernizzi, Michal. Kramer Intraocular tuberculosis (TB) can have several clinical presentations, affecting nearly every tissue of the eye. These clinical [...]

Published
2017

Catalog

Books, media, physical & digital resources
See catalog results